Time to the initiation of adjuvant chemotherapy does not impact survival in patients with resected pancreatic cancer

E-ISSN： 1097-0142|122|19|2979-2987

ISSN： 0008-543x

Source： CANCER, Vol.122, Iss.19, 2016-10, pp. : 2979-2987

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base

CANCER, Vol. 121, Iss. 23, 2015-12 ,pp. : 4141-4149

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Role of Adjuvant Chemotherapy for Patients with Resected Pancreatic Cancer: Systematic Review of Randomized Controlled Trials and Meta-Analysis

Oncology, Vol. 72, Iss. 5-6, 2008-01 ,pp. : 314-321

Karger

Access to resources Recommend Favorite

Use and impact of adjuvant chemotherapy in patients with resected non‐small cell lung cancer

CANCER, Vol. 120, Iss. 13, 2014-07 ,pp. : 1939-1947

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression of the DNA repair gene MLH1 correlates with survival in patients who have resected pancreatic cancer and have received adjuvant chemoradiation: NRG Oncology RTOG Study 9704

CANCER, Vol. 124, Iss. 3, 2018-02 ,pp. : 491-498

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adjuvant Systemic Chemotherapy with or without Bevacizumab in Patients with Resected Liver Metastases from Colorectal Cancer

Oncology, Vol. 84, Iss. 1, 2012-10 ,pp. : 14-21

Karger

Access to resources Recommend Favorite